The Sir Mortimer B. Davis-Jewish General Hospital

Montréal, QC

UEI
EMCNUAEK3UV3
CAGE
L4173
Primary NAICS
622110 General Medical and Surgical Hospitals
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Hospital
  • Non-Profit Organization
Entity structure
Corporate Entity (Tax Exempt)
SAM.gov registration date
Physical address
3755 Chemin de la Côte-Sainte-Catherine, Montréal, QC H3T 1E2, Canada
Website
jgh.ca
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
  4. Health Care Services
SIC code
80 Health Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
SIR mortimer B. Davis-jewish general hospital, the:1146851 [16-053278] HHSN261201600756P National Cancer Institute (NIH) $17,808
Custom items lab testing/SIR mortimer B. Davis-jewish general hospital/tammy cole HHSN261201600637P National Cancer Institute (NIH) $10,650
Lab. Testing for the BREAST radiology evaluation and study of tissues (BREAST) stamp project HHSN261201600140P National Cancer Institute (NIH) $12,572
The BREAST radiology evaluation and study of tissues (BREAST) stamp project: analysis of serum insulin-like growth… HHSN261201500397P National Cancer Institute (NIH) $23,940
Services to perform IGF-1 and igfbp-3 elisa assays on serum collected from 315 participants in the KTB study in order… HHSN261201500248P National Cancer Institute (NIH) $17,640

Latest 5 listed here. See the rest on GovTribe.

Grant awards

Award Agency Obligated Awarded
Discreet and wearable microwave sensing for continuous real-time bladder monitoring HT94252510523 Defense Health Agency $258,173
Systematic approaches to dissect driver pathways in small cell carcinoma of the ovary, hypercalcemic type W81XWH1510497 Department of Defense $439,170
Unlocking barriers to DNA vaccine immunogenicity: a cross-species analysis of cytosolic DNA sensing in skeletal… W81XWH1510505 Department of Defense $219,954
The role of LXR/RXR heterodimers in arsenic-induced atherosclerosis. R21ES014911 National Institutes of Health $295,446
Development of the GAG/lysyl trna synthetase interaction as a target for anti-HIV R01AI077387 National Institutes of Health $2,431,464

Latest 5 listed here. See the rest on GovTribe.

Grant subawards

Prime recipient Prime award Amount Awarded
The Royal Institution For The Advancement Of Learning The team headed by Dr. Uri Saragovi will focus on development of pharmacological agents for TON. Dr. Saragovi will work closely with Drs. Di Polo and Levin, who… W81XWH1910853 $889,756
Pennsylvania State University Subaward site for Role of biomolecular condensates in regulating HIV-1 viral ribonucleoprotein complex formation in the setting of substance use disorder… R33DA053689 $58,400
ST Jude Children's Research Hospital Inc. Deciphering the Role of Aberrant Endogenous Retroviral Expression in Onco-histone Driven Glioma. R01NS116361 $97,019
The Trustees Of Columbia University In The City Of New York Scope of Work: SMBD Jewish General Hospital (Lady Davis Institute for Medical Research) Project Overall Title: Columbia University and Northern Plains… P42ES033719 $32,400
Pennsylvania State University Subaward site for Role of biomolecular condensates in regulating HIV-1 viral ribonucleoprotein complex formation in the setting of substance use disorder… R33DA053689 $59,400

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

Vendor Location Primary NAICS
ST Michael's Hospital UEI W2TKDMBKGQE5 Toronto, ON 622110 General Medical and Surgical Hospitals
Faculté D'Administration UEI N6JXEMKS39F4 Sherbrooke, QC 611310 Colleges, Universities, and Professional Schools
Chum, LE UEI GLYKCC2W6BN7 Montréal, QC —
The Research Institute Of The Mcgill University Health Centre UEI WSJTUAPBJMA4 Montreal, QC 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Research Services Office UEI F2ZFXUC713L3 Edmonton, AB 611310 Colleges, Universities, and Professional Schools

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

The Sir Mortimer B. Davis-Jewish General Hospital, located in Montréal, Quebec, Canada, is a non-profit, tax-exempt hospital registered in the U.S. federal government's System for Award Management (SAM) since 2004. As a research-oriented medical institution, the hospital is affiliated with the Lady Davis Institute for Medical Research and has been active in receiving federal grant awards. The hospital's registration in SAM.gov is current and valid until December 11, 2025, indicating its continued eligibility to participate in federal grant programs.

The Jewish General Hospital has been involved in diverse and sophisticated research projects through federal grant sub-awards and a prime federal grant award. These research endeavors span multiple complex scientific domains, including cardiovascular disease, toxicology, metal exposure studies, HIV-1 viral research, and medical technology development. Specific grant projects include a Defense Health Agency prime award for developing a "discreet and wearable microwave sensing" technology for bladder monitoring, and sub-awards with institutions like Columbia University and Pennsylvania State University. The hospital's research collaborations focus on intricate scientific investigations such as exploring causal molecular mechanisms linking drinking water metal exposures to cardiometabolic disease, analyzing atherosclerosis in mouse models, and investigating biomolecular condensates' role in HIV-1 viral protein complex formation in substance use disorder contexts. These grants demonstrate the hospital's sophisticated research capabilities across medical, technological, and epidemiological domains.

Quick answers

Is The Sir Mortimer B. Davis-Jewish General Hospital registered in SAM.gov?

Yes. The Sir Mortimer B. Davis-Jewish General Hospital's SAM.gov registration is active through November 6, 2026.

What is The Sir Mortimer B. Davis-Jewish General Hospital's CAGE code?

The Sir Mortimer B. Davis-Jewish General Hospital's CAGE code is L4173, and its Unique Entity ID (UEI) is EMCNUAEK3UV3.

What is The Sir Mortimer B. Davis-Jewish General Hospital's most recent federal award?

The Sir Mortimer B. Davis-Jewish General Hospital's most recent federal grant award is Discreet and wearable microwave sensing for continuous real-time bladder monitoring (HT94252510523), from Defense Health Agency, on August 1, 2025.

On GovTribe

See The Sir Mortimer B. Davis-Jewish General Hospital's full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login

Find teaming partners on GovTribe